The COVID-19 pandemic highlights the importance of the prognosis of co-morbidities, such as coronary artery disease, which significantly increase the risk of mortality in patients infected with SARS-CoV2. Investigators have recently studied the complex links between respiratory infections, particularly pneumonia, and type 2 myocardial infarction (MI) in many respects. The etiology of type 2 MI is based on an imbalance of myocardial oxygen supply/need in the absence of rupture/erosion of atheromatous plaques. Based on the RICO survey data, the investigators investigated whether COVID-19-related sepsis and/or respiratory failure could be an underlying mechanism of MI2.
Biological: Biological data
Biological data
Other: Clinical data
Clinical data
Inclusion Criteria:
- patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without
pneumonia
- patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without
COVID 19
Exclusion Criteria:
- None
Chu Dijon Bourgogne
Dijon, France